NEW YORK (GenomeWeb) – 23andMe announced today that it has partnered with Celmatix, a personalized medicine company focused on fertility and women's health, to develop and validate biomarkers to diagnose and treat infertility.

Celmatix will contribute data from its discovery and annotation of more than 5,200 genetic biomarkers related to fertility, and 23andMe will add its genetic database and research community knowledge to the collaboration.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.